APA aipamena

Li, L., Wei, T., Liu, S., Wang, C., Zhao, M., Feng, Y., . . . Liu, J. (2020). Complement C5 activation promotes type 2 diabetic kidney disease via activating STAT3 pathway and disrupting the gut‐kidney axis. J Cell Mol Med.

Chicago Style aipamena

Li, Ling, et al. "Complement C5 Activation Promotes Type 2 Diabetic Kidney Disease Via Activating STAT3 Pathway and Disrupting the Gut‐kidney Axis." J Cell Mol Med 2020.

MLA aipamena

Li, Ling, et al. "Complement C5 Activation Promotes Type 2 Diabetic Kidney Disease Via Activating STAT3 Pathway and Disrupting the Gut‐kidney Axis." J Cell Mol Med 2020.

Kontuz: berrikusi erreferentzia hauek erabili aurretik.